Literature DB >> 25047849

Porphyromonas gingivalis lipopolysaccharide weakly activates M1 and M2 polarized mouse macrophages but induces inflammatory cytokines.

James A Holden1, Troy J Attard1, Katrina M Laughton1, Ashley Mansell2, Neil M O'Brien-Simpson1, Eric C Reynolds3.   

Abstract

Porphyromonas gingivalis is associated with chronic periodontitis, an inflammatory disease of the tooth's supporting tissues. Macrophages are important in chronic inflammatory conditions, infiltrating tissue and becoming polarized to an M1 or M2 phenotype. As responses to stimuli differ between these phenotypes, we investigated the effect of P. gingivalis lipopolysaccharide (LPS) on M1 and M2 macrophages. M1 and M2 polarized macrophages were produced from murine bone marrow macrophages (BMMϕ) primed with gamma interferon (IFN-γ) or interleukin-4 (IL-4), respectively, and incubated with a low or high dose of P. gingivalis LPS or control TLR2 and TLR4 ligands. In M1-Mϕ, the high dose of P. gingivalis LPS (10 μg/ml) significantly increased the expression of CD40, CD86, inducible nitric oxide synthase, and nitric oxide secretion. The low dose of P. gingivalis LPS (10 ng/ml) did not induce costimulatory or antibacterial molecules but did increase the secretion of IL-1α, IL-6, IL-12p40, IL-12p70, and tumor necrosis factor alpha (TNF-α). P. gingivalis LPS marginally increased the expression of CD206 and YM-1, but it did enhance arginase expression by M2-Mϕ. Furthermore, the secretion of the chemokines KC, RANTES, eotaxin, and MCP-1 from M1, M2, and nonpolarized Mϕ was enhanced by P. gingivalis LPS. TLR2/4 knockout macrophages combined with the TLR activation assays indicated that TLR2 is the main activating receptor for P. gingivalis LPS and whole cells. In conclusion, although P. gingivalis LPS weakly activated M1-Mϕ or M2-Mϕ compared to control TLR ligands, it induced the secretion of inflammatory cytokines, particularly TNF-α from M1-Mϕ and IL-10 from M2-Mϕ, as well as chemotactic chemokines from polarized macrophages.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25047849      PMCID: PMC4187848          DOI: 10.1128/IAI.02325-14

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  64 in total

Review 1.  Bioactive mechanism of Porphyromonas gingivalis lipid A.

Authors:  Tomohiko Ogawa; Takakazu Yagi
Journal:  Periodontol 2000       Date:  2010-10       Impact factor: 7.589

2.  Altered distribution of type I collagen mRNA in periodontal disease.

Authors:  H Larjava; M Sandberg; E Vuorio
Journal:  J Periodontal Res       Date:  1989-05       Impact factor: 4.419

Review 3.  Host immune responses to Porphyromonas gingivalis antigens.

Authors:  Rishi D Pathirana; Neil M O'Brien-Simpson; Eric C Reynolds
Journal:  Periodontol 2000       Date:  2010-02       Impact factor: 7.589

4.  Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2.

Authors:  M Hirschfeld; Y Ma; J H Weis; S N Vogel; J J Weis
Journal:  J Immunol       Date:  2000-07-15       Impact factor: 5.422

5.  Immunohistochemical study of types I, III and IV collagen in fibrosis of diseased gingiva during chronic periodontitis: a light and electron microscopic study.

Authors:  C Chavrier; M L Couble; D Hartmann; J A Grimaud; H Magloire
Journal:  J Periodontal Res       Date:  1987-01       Impact factor: 4.419

6.  Heme Oxygenase-1 expression in M-CSF-polarized M2 macrophages contributes to LPS-induced IL-10 release.

Authors:  Elena Sierra-Filardi; Miguel A Vega; Paloma Sánchez-Mateos; Angel L Corbí; Amaya Puig-Kröger
Journal:  Immunobiology       Date:  2010-06-08       Impact factor: 3.144

7.  Temperature-dependent modulation of Porphyromonas gingivalis lipid A structure and interaction with the innate host defenses.

Authors:  Michael A Curtis; Rimondia S Percival; Deirdre Devine; Richard P Darveau; Stephen R Coats; Minnie Rangarajan; Edward Tarelli; Philip D Marsh
Journal:  Infect Immun       Date:  2011-01-10       Impact factor: 3.441

Review 8.  Monocytes and macrophages as cellular targets in liver fibrosis.

Authors:  Felix Heymann; Christian Trautwein; Frank Tacke
Journal:  Inflamm Allergy Drug Targets       Date:  2009-09

9.  Differential expression of immunoregulatory genes in monocytes in response to Porphyromonas gingivalis and Escherichia coli lipopolysaccharide.

Authors:  H E Barksby; C J Nile; K M Jaedicke; J J Taylor; P M Preshaw
Journal:  Clin Exp Immunol       Date:  2009-06       Impact factor: 4.330

10.  Human Toll-like receptor 4 responses to P. gingivalis are regulated by lipid A 1- and 4'-phosphatase activities.

Authors:  Stephen R Coats; Jace W Jones; Christopher T Do; Pamela H Braham; Brian W Bainbridge; Thao T To; David R Goodlett; Robert K Ernst; Richard P Darveau
Journal:  Cell Microbiol       Date:  2009-06-13       Impact factor: 3.715

View more
  37 in total

1.  IL-1R/TLR2 through MyD88 Divergently Modulates Osteoclastogenesis through Regulation of Nuclear Factor of Activated T Cells c1 (NFATc1) and B Lymphocyte-induced Maturation Protein-1 (Blimp1).

Authors:  Zhihong Chen; Lingkai Su; Qingan Xu; Jenny Katz; Suzanne M Michalek; Mingwen Fan; Xu Feng; Ping Zhang
Journal:  J Biol Chem       Date:  2015-10-19       Impact factor: 5.157

2.  Gingipain of Porphyromonas gingivalis manipulates M1 macrophage polarization through C5a pathway.

Authors:  Yubo Hou; Haiyan Yu; Xinchan Liu; Gege Li; Jiahui Pan; Changyu Zheng; Weixian Yu
Journal:  In Vitro Cell Dev Biol Anim       Date:  2017-06-20       Impact factor: 2.416

3.  Porphyromonas gulae Activates Unprimed and Gamma Interferon-Primed Macrophages via the Pattern Recognition Receptors Toll-Like Receptor 2 (TLR2), TLR4, and NOD2.

Authors:  James A Holden; Neil M O'Brien-Simpson; Jason C Lenzo; Rebecca K H Orth; Ashley Mansell; Eric C Reynolds
Journal:  Infect Immun       Date:  2017-08-18       Impact factor: 3.441

4.  Alveolar bone loss in relation to toll-like receptor 4 and 9 genotypes and Porphyromonas gingivalis carriage.

Authors:  U K Gursoy; Q He; P Pussinen; S Huumonen; E Könönen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-08-04       Impact factor: 3.267

5.  Macrophage subsets exhibit distinct E. coli-LPS tolerisable cytokines associated with the negative regulators, IRAK-M and Tollip.

Authors:  Khalid Al-Shaghdali; Barbara Durante; Christopher Hayward; Jane Beal; Andrew Foey
Journal:  PLoS One       Date:  2019-05-23       Impact factor: 3.240

6.  Induction of inducible nitric oxide synthase (iNOS) in Porphyromonas gingivalis LPS-treated mouse macrophage cell line (RAW264.7) requires Toll-like receptor 9.

Authors:  Matsayapan Pudla; Ratchapin Srisatjaluk; Pongsak Utaisincharoen
Journal:  Inflamm Res       Date:  2018-07-06       Impact factor: 4.575

7.  Anti-Inflammatory Effects of an Extract from Pseudomonas aeruginosa and Its Purified Product 1-Hydroxyphenazine on RAW264.7 Cells.

Authors:  Jun Xiao; Aye Aye Thwe; Tingting Liu; Dafei Gong; Wanhua Lin; Changhua Shang; ZuJun Lu
Journal:  Curr Microbiol       Date:  2021-05-27       Impact factor: 2.188

8.  Gingipains from the Periodontal Pathogen Porphyromonas gingivalis Play a Significant Role in Regulation of Angiopoietin 1 and Angiopoietin 2 in Human Aortic Smooth Muscle Cells.

Authors:  Boxi Zhang; Hazem Khalaf; Allan Sirsjö; Torbjörn Bengtsson
Journal:  Infect Immun       Date:  2015-08-17       Impact factor: 3.441

9.  Immunologic environment influences macrophage response to Porphyromonas gingivalis.

Authors:  G Papadopoulos; Y B Shaik-Dasthagirisaheb; N Huang; G A Viglianti; A J Henderson; A Kantarci; F C Gibson
Journal:  Mol Oral Microbiol       Date:  2016-08-26       Impact factor: 3.563

10.  Macrophage polarization in response to oral commensals and pathogens.

Authors:  Chifu B Huang; Yelena Alimova; Jeffrey L Ebersole
Journal:  Pathog Dis       Date:  2016-02-15       Impact factor: 3.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.